Page last updated: 2024-10-30

mesalamine and Lymphocytosis

mesalamine has been researched along with Lymphocytosis in 2 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Lymphocytosis: Excess of normal lymphocytes in the blood or in any effusion.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fernández-Bañares, F1
Salas, A1
Esteve, M1
Espinós, J1
Forné, M1
Viver, JM1
Kondo, H1
Watanabe, J1
Iwasaki, H1

Other Studies

2 other studies available for mesalamine and Lymphocytosis

ArticleYear
Collagenous and lymphocytic colitis. evaluation of clinical and histological features, response to treatment, and long-term follow-up.
    The American journal of gastroenterology, 2003, Volume: 98, Issue:2

    Topics: Aged; Budesonide; Cholestyramine Resin; Colitis; Collagen; Colon; Female; Follow-Up Studies; Humans;

2003
T-large granular lymphocyte leukemia accompanied by an increase of natural killer cells (CD3-) and associated with ulcerative colitis and autoimmune hepatitis.
    Leukemia & lymphoma, 2001, Volume: 41, Issue:1-2

    Topics: Anti-Inflammatory Agents; Colitis, Ulcerative; Gene Rearrangement; Genes, T-Cell Receptor beta; Hepa

2001